![]() |
|
|
Vol. 27, Issue 4, 542-548, April 1999
Department of Pharmacology, The distribution of several cytochrome P-450 (P-450) isoenzymes
between proximal tubular (PT) and distal tubular (DT) cells of the rat
kidney was determined. Western blot analysis of microsomes prepared
from liver and kidney cortical homogenates revealed that CYP2E1 protein
was expressed in rat kidney microsomes at approximately 10% of hepatic
levels. Microsomes from renal cortical, PT, and DT cells all expressed
CYP2E1, with DT microsomes expressing slightly higher levels than PT
microsomes. In contrast, chlorzoxazone hydroxylation activity was
markedly higher in microsomes from PT cells than in those from DT
cells. Northern blot analysis of total RNA from PT and DT cells
exhibited a pattern of CYP2E1 mRNA distribution similar to that of
CYP2E1 protein. CYP2C11 protein expression in renal cortical microsomes
was approximately 10% of that in liver microsomes but was
significantly higher in microsomes from PT cells than in those from DT
cells. CYP3A1/2 was not detected in microsomes from either cortical,
PT, or DT cells, but was detected in microsomes isolated from total
liver or kidney cortical homogenates. CYP2B1/2 expression was detected
in all tissues tested. The peroxisomal proliferator clofibrate enhanced
the level of CYP2B1/2 in microsomes from both total liver and kidney
cortical homogenates but not in microsomes from cortical, PT, or DT
cells. CYP4A2/3 protein and CYP4A mRNA expression were detected in
microsomes from total liver and kidney cortical homogenates and from
renal cortical, PT, and DT cells using Western and Northern blot
analyses, respectively. Lauric acid hydroxylation activity, an
indicator of CYP4A, was comparable in PT and DT cells. Clofibrate
elevation of CYP4A in cortical, PT, and DT microsomes was not as great
as that detected in total kidney cortical microsomes. These results
establish the distribution of several P-450 isoenzymes between
different cell populations of the rat kidney. Furthermore, these
results present evidence that the level of induction of certain P-450
isoenzymes in the kidney is cell type-specific.
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
Y. Zhou, H. Huang, H.-H. Chang, J. Du, J. F. Wu, C.-Y. Wang, and M.-H. Wang Induction of Renal 20-Hydroxyeicosatetraenoic Acid by Clofibrate Attenuates High-Fat Diet-Induced Hypertension in Rats J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Lash and J. C. Parker Hepatic and Renal Toxicities Associated with Perchloroethylene Pharmacol. Rev., May 11, 2001; (2001) 2. [Abstract] [Full Text] |
||||
![]() |
B. S. Cummings, J. C. Parker, and L. H. Lash Cytochrome P450-Dependent Metabolism of Trichloroethylene in Rat Kidney Toxicol. Sci., March 1, 2001; 60(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Cummings, J. M. Lasker, and L. H. Lash Expression of Glutathione-Dependent Enzymes and Cytochrome P450s in Freshly Isolated and Primary Cultures of Proximal Tubular Cells from Human Kidney J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 677 - 685. [Abstract] [Full Text] |
||||
![]() |
J. M. Lasker, W. B. Chen, I. Wolf, B. P. Bloswick, P. D. Wilson, and P. K. Powell Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human Kidney. ROLE OF CYP4F2 AND CYP4A11 J. Biol. Chem., February 11, 2000; 275(6): 4118 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Cummings and L. H. Lash Metabolism and Toxicity of Trichloroethylene and S-(1,2-Dichlorovinyl)-L-Cysteine in Freshly Isolated Human Proximal Tubular Cells Toxicol. Sci., February 1, 2000; 53(2): 458 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Lash and J. C. Parker Hepatic and Renal Toxicities Associated with Perchloroethylene Pharmacol. Rev., June 1, 2001; 53(2): 177 - 208. [Abstract] [Full Text] [PDF] |
||||